1.85
-0.14 (-7.04%)
-0.14 (-7.04%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 45,350 |
|
|||||
| News | (1) | ||||||
| Day High | 2.00 | Low High |
|||||
| Day Low | 1.86 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.14 | -7.04% | 1.85 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.00 | 1.86 | 2.00 | 1.88 | 1.99 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 397 | 45,350 | $ 1.90 | $ 86,248 | - | 1.86 - 5.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:53:41 | 1 | $ 1.85 | USD |
Period:
Draw Mode:
Acer Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 26.47M | 14.31M | 9.44M | $ - | $ - | -2.06 | -1.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 223.57k | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.20 | 2.25 | 1.86 | 2.06 | 62,951 | -0.35 | -15.91% |
| 1 Month | 2.46 | 2.66 | 1.86 | 2.31 | 72,620 | -0.61 | -24.8% |
| 3 Months | 2.69 | 3.04 | 1.86 | 2.77 | 314,547 | -0.84 | -31.23% |
| 6 Months | 2.88 | 3.14 | 1.86 | 2.74 | 264,204 | -1.03 | -35.76% |
| 1 Year | 2.69 | 5.39 | 1.86 | 3.46 | 522,568 | -0.84 | -31.23% |
| 3 Years | 23.40 | 28.2475 | 1.08 | 4.06 | 280,673 | -21.55 | -92.09% |
| 5 Years | 8.55 | 34.10 | 1.08 | 4.77 | 209,453 | -6.70 | -78.36% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
